Clinical Trial Update: Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma [Phase 1]

View source ↗

Summary

Phase 1 clinical trial of targeted alpha particle radiotherapy for metastatic uveal melanoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveal Melanoma

Snippet

Sponsor: Modulation Therapeutics, Inc. | Conditions: Uveal Melanoma, Metastatic | Phase 1 | Status: ACTIVE_NOT_RECRUITING